Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018

Summary Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018. The report is an essential source of information and analysis on the global Unstable Angina Therapeutics market. The report identifies the key trends shaping and driving the global Unstable Angina Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Unstable Angina Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope The report provides information on the key drivers and challenges of the Unstable Angina Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Unstable Angina Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Unstable Angina Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Unstable Angina Therapeutics market. - Analysis of key recent licensing and partnership agreements in Unstable Angina Therapeutics market Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Unstable Angina Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Unstable Angina Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Unstable Angina Therapeutics market landscape? – Identify, understand and capitalize. 1.1 List of Tables 5 1.2 List of Figures 6 2 Unstable Angina Therapeutics - Introduction 7 2.1 Disease Overview 7 2.2 Epidemiology 8 2.3 Etiology and Pathophysiology 9 2.3.1 Etiology of Unstable Angina 9 2.3.2 Pathophysiology of Unstable Angina 10 2.4 Signs and Symptoms 11

2.5 Diagnosis 12 2.6 Treatment and Management Options 12 2.7 Lifestyle Changes 13 2.8 Medical Treatment 13 2.8.1 Medical Procedures 14 2.8.2 Cardiac Rehabilitation 14 2.9 GlobalData Pipeline Report Guidance 15 3 Unstable Angina Therapeutics - Market Characterization 16 3.1 Unstable Angina Therapeutics Market Size (2005-2010) - Global 16 3.2 Unstable Angina Therapeutics Market Forecast (2010-2018) - Global 18 3.3 Unstable Angina Therapeutics Market Size (2005-2010) - the US 19 3.4 Unstable Angina Therapeutics Market Forecast (2010-2018) - the US 20 3.5 Unstable Angina Therapeutics Market Size (2005-2010) - France 21 3.6 Unstable Angina Therapeutics Market Forecast (2010-2018) - France 22 3.7 Unstable Angina Therapeutics Market Size (2005-2010) - Germany 23 3.8 Unstable Angina Therapeutics Market Forecast (2010-2018) - Germany 24 3.9 Unstable Angina Therapeutics Market Size (2005-2010) - Italy 25 3.10 Unstable Angina Therapeutics Market Forecast (2010-2018) - Italy 26 3.11 Unstable Angina Therapeutics Market Size (2005-2010) - Spain 27 3.12 Unstable Angina Therapeutics Market Forecast (2010-2018) - Spain 28 3.13 Unstable Angina Therapeutics Market Size (2005-2010) - the UK 29 3.14 Unstable Angina Therapeutics Market Forecast (2010-2018) - the UK 30 3.15 Unstable Angina Therapeutics Market Size (2005-2010) - Japan 31 3.16 Unstable Angina Therapeutics Market Forecast (2010-2018) - Japan 32 3.17 Drivers and Barriers for the Unstable Angina Therapeutics Market 33 3.17.1 Drivers for the Unstable Angina Therapeutics Market 33 3.17.2 Barriers for the Unstable Angina Therapeutics Market 34 3.18 Opportunity and Unmet Need 34 3.19 Key Takeaway 35 4 Unstable Angina Therapeutics - Competitive Assessment 36 4.1 Overview 36 4.2 Strategic Competitor Assessment 36 4.3 Major Marketed Products Profiles for the Unstable Angina Therapeutics Market 38 4.3.1 Low Molecular Weight Heparins 38 4.3.2 Glycoprotein IIb/IIIa Inhibitor 39 4.3.3 Sodium Channel Current Inhibitor 43 4.3.4 Nitrates 45 4.3.5 Beta-adrenergic Receptor Blockers (Beta Blockers) 45 4.3.6 Calcium Channel Blockers 46 4.3.7 Angiotensin Converting Enzyme Inhibitor 47 4.3.8 Statins 47 4.3.9 Selective If Channel Inhibitor 49 4.4 Key Takeaway 51 5 Unstable Angina Therapeutics - Pipeline Assessment 52 5.1 Overview 52 5.2 Strategic Pipeline Assessment 52 5.3 Unstable Angina Therapeutics - Pipeline Analysis by Clinical Phase of Development 53 5.3.1 Unstable Angina Therapeutics - Phase III Clinical Pipeline 53 5.3.2 Unstable Angina Therapeutics - Phase II Clinical Pipeline 53 5.3.3 Unstable Angina Therapeutics - Phase I Clinical Pipeline 54 5.3.4 Unstable Angina Therapeutics - Preclinical Phase Pipeline 54 5.4 Unstable Angina Therapeutics - Pipeline by Mechanism of Action 55 5.5 Technology Trends Analytical Framework 56 5.6 Unstable Angina Therapeutics - Most Promising Drugs in Clinical Development 57 5.7 Most Promising Drug Profiles 57 5.7.1 Rivaroxaban 57 5.7.2 Otamixaban 58 5.7.3 A-002 (Varespladib Methyl) 59 5.8 Key Takeaway 60 6 Unstable Angina Therapeutics - Clinical Trials Mapping 61 6.1 Clinical Trials by Region/Country (the US, EU5 and Japan) 61 6.2 Clinical Trials by Phase of Clinical Development 62 6.3 Clinical Trials by Trial Status 63 6.4 Prominent Sponsors 64

6.5 Clinical Trials by Sponsors 65 6.6 Top Companies Participating in Unstable Angina Therapeutics Clinical Trials 66 7 Unstable Angina Therapeutics - Strategic Assessment 67 7.1 Key Events Impacting the Future Market 67 7.2 Future Market Competition Scenario 68 8 Unstable Angina Therapeutics - Future Players 69 8.1 Introduction 69 8.2 Company Profiles 70 8.2.1 Anthera Pharmaceuticals 70 8.2.2 Bayer HealthCare 70 8.2.3 Sanofi 71 8.2.4 Ablynx 72 8.2.5 Cytokinetics 73 8.3 Other Companies in the Unstable Angina Therapeutics Market 75 8.4 Key Takeaway 75 9 Unstable Angina Therapeutics - Licensing & Partnership Deals 76 10 Unstable Angina Therapeutics - Appendix 79 10.1 Definitions 79 10.2 Acronyms 79 10.3 Research Methodology 81 10.3.1 Coverage 81 10.3.2 Secondary Research 81 10.3.3 Forecasting 82 10.3.4 Primary Research 85 10.3.5 Expert Panel Validation 85 10.4 Contact Us 85 10.5 Disclaimer 85 10.6 Bibliography 86 1.1 List of Tables Table 1: Canadian Cardiovascular Society Grading of Angina Pectoris 8 Table 2: Unstable Angina Prevalence in Seven Major Markets 8 Table 3: Unstable Angina Therapeutics Market, Global, Revenue ($m), 2005-2010 17 Table 4: Unstable Angina Therapeutics Market, Global, Forecast ($m), 2010-2018 18 Table 5: Unstable Angina Therapeutics Market, the US, Revenue ($m), 2005-2010 19 Table 6: Unstable Angina Therapeutics Market, the US, Forecast ($m), 2010-2018 20 Table 7: Unstable Angina Therapeutics Market, France, Revenue ($m), 2005-2010 21 Table 8: Unstable Angina Therapeutics Market, France, Forecast ($m), 2010-2018 22 Table 9: Unstable Angina Therapeutics Market, Germany, Revenue ($m), 2005-2010 23 Table 10: Unstable Angina Therapeutics Market, Germany, Forecast ($m), 2010-2018 24 Table 11: Unstable Angina Therapeutics Market, Italy, Revenue ($m), 2005-2010 25 Table 12: Unstable Angina Therapeutics Market, Italy, Forecast ($m), 2010-2018 26 Table 13: Unstable Angina Therapeutics Market, Spain, Revenue ($m), 2005-2010 27 Table 14: Unstable Angina Therapeutics Market, Spain, Forecast ($m), 2010-2018 28 Table 15: Unstable Angina Therapeutics Market, the UK, Revenue ($m), 2005-2010 29 Table 16: Unstable Angina Therapeutics Market, the UK, Forecast ($m), 2010-2018 30 Table 17: Unstable Angina Therapeutics Market, Japan, Revenue ($m), 2005-2010 31 Table 18: Unstable Angina Therapeutics Market, Japan, Forecast ($m), 2010-2018 32 Table 19: Comparison of Major Marketed Products in the Unstable Angina Therapeutics Market, 2011 50 Table 20: Unstable Angina Therapeutics Market, Phase III and Regulatory Filed Pipeline, 2011 53 Table 21: Unstable Angina Therapeutics Market, Phase II Pipeline, 2011 53 Table 22: Unstable Angina Therapeutics Market, Phase I Pipeline, 2011 54 Table 23: Unstable Angina Therapeutics Market, Pre-clinical and Discovery Phase Pipeline, 2011 54 Table 24: Unstable Angina Therapeutics Market, Global, Most Promising Drugs in Clinical Development, 2011 57 Table 25: Unstable Angina Therapeutics, Global, Clinical Trials, 2011 61 Table 26: Unstable Angina Therapeutics, Global, Clinical Trials by Phase, 2011 62 Table 27: Unstable Angina Therapeutics, Global, Clinical Trials by Status of Development, 2011 63 Table 28: Unstable Angina Therapeutics, Global, Prominent Sponsors, 2011 64 Table 29: Unstable Angina Therapeutics, Global, Overall Sponsors, 2011 65 Table 30: Unstable Angina Therapeutics, Global, Top Five Companies by Phase, 2011 66 Table 31: Anthera Pharmaceuticals - Unstable Angina, Pipeline, 2011 70 Table 32: Bayer HealthCare - Unstable Angina, Pipeline, 2011 71 Table 33: Sanofi - Unstable Angina, Pipeline, 2011 72

Table Table Table Table

34: 35: 36: 37:

Ablynx - Unstable Angina, Pipeline, 2011 73 Cytokinetics - Unstable Angina, Pipeline, 2011 74 Other Companies in the Unstable Angina Therapeutics Market 75 Unstable Angina Therapeutics, Global, Deals - 2011 76

1.2 List of Figures Figure 1: Graphic Presentation of Unstable Angina 7 Figure 2: Impact of Atherosclerosis on Arteries 9 Figure 3: Progression of Coronary Artery Disease (CAD) 11 Figure 4: Unstable Angina Therapeutics Market, Global, Revenue ($m), 2005-2010 17 Figure 5: Unstable Angina Therapeutics Market, Global, Forecast ($m), 2010-2018 18 Figure 6: Unstable Angina Therapeutics Market, the US, Revenue ($m), 2005-2010 19 Figure 7: Unstable Angina Therapeutics Market, the US, Forecast ($m), 2010-2018 20 Figure 8: Unstable Angina Therapeutics Market, France, Revenue ($m), 2005-2010 21 Figure 9: Unstable Angina Therapeutics Market, France, Forecast ($m), 2010-2018 22 Figure 10: Unstable Angina Therapeutics Market, Germany, Revenue ($m), 2005-2010 23 Figure 11: Unstable Angina Therapeutics Market, Germany, Forecast ($m), 2010-2018 24 Figure 12: Unstable Angina Therapeutics Market, Italy, Revenue ($m), 2005-2010 25 Figure 13: Unstable Angina Therapeutics Market, Italy, Forecast ($m), 2010-2018 26 Figure 14: Unstable Angina Therapeutics Market, Spain, Revenue ($m), 2005-2010 27 Figure 15: Unstable Angina Therapeutics Market, Spain, Forecast ($m), 2010-2018 28 Figure 16: Unstable Angina Therapeutics Market, the UK, Revenue ($m), 2005-2010 29 Figure 17: Unstable Angina Therapeutics Market, the UK, Forecast ($m), 2010-2018 30 Figure 18: Unstable Angina Therapeutics Market, Japan, Revenue ($m), 2005-2010 31 Figure 19: Unstable Angina Therapeutics Market, Japan, Forecast ($m), 2010-2018 32 Figure 20: Opportunity and Unmet Need in the Unstable Angina Therapeutics Market 35 Figure 21: Strategic Competitor Assessment of the Marketed Products in Unstable Angina Therapeutics, 2011 37 Figure 22: Unstable Angina Therapeutics Pipeline by Phase of Clinical Development, 2011 53 Figure 23: Unstable Angina Therapeutics Market, Global, Pipeline by Mechanism of Action (%), 2011 55 Figure 24: Technology Trends Analytics Framework, 2011 56 Figure 25: Technology Trends Analytics Frame Work - Description, 2011 56 Figure 26: Unstable Angina Therapeutics, Global, Clinical Trials by Country, 2011 61 Figure 27: Unstable Angina Therapeutics, Global, Clinical Trials by Phase (%), 2011 62 Figure 28: Unstable Angina Therapeutics, Global, Clinical Trials by Status of Development (%), 2011 63 Figure 29: Unstable Angina Therapeutics, Global, Prominent Sponsors (%), 2011 64 Figure 30: Unstable Angina Therapeutics, Global, Overall Sponsors (%), 2011 65 Figure 31: Unstable Angina Therapeutics, Global, Top Five Companies by Phase, 2011 66 Figure 32: Unstable Angina Therapeutics Market, Drivers and Restraints, 2011 67 Figure 33: Implications for Future Market Competition in the Unstable Angina Therapeutics Market, 2011 68 Figure 34: Unstable Angina Therapeutics Market, Global, Future Players, 2011 69 Figure 35: GlobalData Market Forecasting Model 84 Anthera Pharmaceuticals Bayer HealthCare Sanofi Ablynx Cytokinetics

For more information, please visit: http://www.aarkstore.com/reports/Unstable-Angina-Therapeutics-Pipeline-Assessment-andMarket-Forecast-to-2018-191433.html Or email us at contact@aarkstore.com or call +918149852585
More Reports Solar Module Recycling - A Necessary Step to Maximize Environmental Benefits of Solar PV Industry Geothermal Power - Global Market Size, Technology Analysis, Regulations and Key Country Analysis to 2020 Advanced Clean Energy Storage Devices - Global Market Size, Market Analysis by Major Storage Device, and

Competitive Landscape to 2020 Thin-Film PV - Global Market Size, Price Analysis, Regulations and Competitive Landscape to 2020 Wind Operations & Maintenance (O&M) Market - Global Market Size, Share by Component, Competitive Landscape and Key Country Analysis to 2020 Compact Fluorescent Lamp (CFL) Market - Global Market Size, Price Analysis, Regulations and Key Countries Analysis to 2020 Biofuels (Biodiesel and Bioethanol) Market - Global Production, Regulations, Export-Import Analysis and Key Country Analysis to 2020 Wind Repowering - Capacity, Generation and Cost-Benefit Analysis to 2020 Oil and Gas Capital Expenditure Outlook, 2012 Offshore Oil and Gas Developments in Asia-Pacific - Burgeoning Energy Demand Drives Exploration and Production Activities Strategic Pipelines Set to Change Geopolitical and Demand Supply Paradigm in the Global Oil and Gas Industry Coal Seam Gas (CSG/CBM) in Asia, 2011 - Market Analysis, Investment Scenario, Competitive Landscape and Production Forecasts to 2015 Refining Industry in Asia-Pacific - Market Analysis, Competitive Landscape and Capacity Forecasts to 2016 Floating Production Storage and Offloading (FPSO) Industry - Global Market Analysis, Competitive Landscape and Planned Projects to 2015 Bakken Shale, 2011 - Oil Shale Market Analysis and Forecasts to 2020 Fayetteville Shale in the US, 2011 - Gas Shale Market Analysis and Forecasts to 2020 Niobrara Shale in the US, 2012 - Oil Shale Market Analysis and Forecasts to 2020 Utica Shale, 2012 - Oil and Gas Market Analysis and Forecasts to 2020 Haynesville Shale in the US, 2012 - Gas Shale Market Analysis and Forecasts to 2020 Montney Shale in Canada, 2012 - Gas Shale Market Analysis and Forecasts to 2020 Nuclear Condensate and Feed Water Pumps - Global Market Size, Pricing, Regional Analysis and Competitive Landscape to 2020 Nuclear Moisture Separator Reheaters Market - Global Market Size, Pricing Analysis, Regional Analysis and Competitive Landscape to 2020 Plant Life Extension (PLEX) and Plant Life Management (PLIM) for Nuclear Reactors - Global Landscape Analysis to 2020 Phase Shifting Transformers for Power Transmission - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 High-Voltage Direct Current (HVDC) Converter Stations - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Steam Turbines in Asia-Pacific - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Shunt Reactor for Power Transmission - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Power Boilers in Asia Pacific - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Gas Turbines in BRIC (Brazil, Russia, India and China) - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Heat Recovery Steam Generator (HRSG) Market in Asia-Pacific Region - Market Size, Pricing Analysis, Equipment Market Share and Competitive Landscape Analysis to 2020 High Voltage Direct Current (HVDC) Cables - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Gas Turbines for Thermal Power - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Wireless Communication Modules for Smart Meters - Market Analysis and Forecasts to 2020 Smart Grid Vendor Landscape Analysis - Strategic Activity Analysis and Outlook to 2015 In-Home Displays for Energy Management - Market Analysis and Forecasts to 2020 Smart Grid Market and Technology Outlook - Industry Trends and Competitive Analysis Smart Grid Landscape in Europe - Market Size, Key Issues, Regulations, Investment Analysis and Outlook to 2020 Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Eczema Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Overactive Bladder (OAB) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018 Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Rhabdomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Interstitial Cystitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Athlete’s Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Lyme Disease - Pipeline Assessment and Market Forecasts to 2018 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Graves’ Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019 Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019 Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019 Cushing’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aspergillosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Waldenström’s Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Refractive Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Multiparameter Patient Monitoring - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Hearing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Electrosurgical Devices Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Infusion Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Compression Therapy - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Wound Closure Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Non-Invasive Blood Pressure Monitors Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Patient Monitoring Accessories (Patient Monitoring Leads and Electrodes, Non-Invasive Blood Pressure Cuffs and Patient Monitoring Temperature Probes) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Compression Therapy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Traditional Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Wound Closure Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Advanced Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Ostomy Drainage Bags Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Negative Pressure Wound Therapy (NPWT) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Flexible Endoscopes Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Rigid Endoscopes Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Capsule Endoscope Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Aarkstore Enterprise Tel : +912227453309 Mobile No:+08149852585 Email : contact@aarkstore.com Website : http://www.aarkstore.com Blog: http://www.emarketreports.com Follow us on twitter: http://twitter.com/aarkstoredotcom http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstoreenterprise http://www.aarkstore.com/feeds/globaldata.xml

Sign up to vote on this title
UsefulNot useful